Christopher B Ehrlich insider trades
Open-market stock purchases and sales by Christopher B Ehrlich, Chairman and CEO at Cero Therapeutics Holdings, Inc, from SEC Form 4 filings since Jan 14, 2010.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 7, 2026 | CERO Cero Therapeutics Holdings, Inc | Bought (not open market) | — |
Companies traded
- CERO Cero Therapeutics Holdings, Inc: other filings, last Jan 7, 2026
- EFTR eFFECTOR Therapeutics, Inc: 9 buys, last Jun 13, 2024
- PBAX Phoenix Biotech Acquisition Corp: other filings, last Oct 8, 2021
- LWAC Locust Walk Acquisition Corp: other filings, last Jan 12, 2021
- TSPT Transcept Pharmaceuticals Inc: 2 buys, last Apr 10, 2013
- BMTI Biomimetic Therapeutics, Inc: other filings, last Mar 1, 2013
Get free alerts when Christopher B Ehrlich files a new trade →